Portfolio

Clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.

Tech-enabled Medicare Advantage company that partners with local providers to deliver high-quality, low-cost coordinated care.

Clinical-stage drug development company pioneering precision psychiatry by developing targeted medicines to help patients get better faster.

Clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders.

Clinical-stage immunology focused biopharmaceutical company developing therapies for atopic dermatitis and asthma.

A Digital Therapeutics™ Company pioneering software solutions as prescription medical treatments.

Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.

Innovative diabetes-focused medical device company that developed the first and only FDA-cleared smart insulin pen and app system.

Clinical-stage drug development company pioneering transformative medicines to treat inflammatory and fibrotic diseases by targeting the endocannabinoid system.

Comprehensive kidney care provider with a personalized, evidence-based approach to managing chronic kidney disease (CKD) and end-stage renal disease (ESRD).

A comprehensive in-home, high acuity medical care provider bringing the power of the hospital to the comfort of the home.

Clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers.

Clinical-stage biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects.

Founded to transform rural healthcare across America through advanced primary care.

Agricultural biotechnology company that uses genetic technologies and data science to develop next-generation seeds.

Clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization.

Clinical-stage biopharmaceutical company leveraging a proprietary microRNA based target discovery platform to develop first-in-class small molecule and antibody cancer therapeutics.

Multi-platform technology company that unlocks the potential of our planet’s interdependent natural systems to solve pressing agriculture, nutrition & environmental challenges.

Clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases.

Clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics called engineered toxin bodies (ETBs).

Clinical-stage biopharmaceutical company developing next-generation, systemically active viral immunotherapies for cancer.

Preclinical-stage biotechnology company pioneering an entirely new platform of allogeneic cell therapies based on platelet biology.

Clinical stage biotechnology company developing therapeutics targeting stress support pathways

Clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment.

Medical device company pioneering integrated visualization devices for orthopedic diagnostics

Dedicated to creating life-changing T Cell therapies for patients by unleashing the untapped potential of the human immune system.

Commercial-stage biopharmaceutical company developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology.

A 24/7 clinical provider group and digital health platform, dedicated to supporting high needs members at home and connecting their caregivers’ insights to the rest of the care team